Bristol-Myers Squibb: BMS Scores Two on Tuesday With Colorectal Cancer Approval, Court Win

The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action complaint over the blood cancer drug Pomalyst.